Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam or propofol plus remifentanil for hysteroscopy anesthesia
ChiCTR2200062064Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in procedural pain, anxiety disorder and None comparing Propofol + remifentanil with Remimazolam + remifentanil (2 arms). Primary endpoints: Efficacy and Depth of anesthesia (MOAA/S and BIS). Planned start Jul 2022; status: not yet recruiting.
02
Drugs
remimazolampropofolremifentanil
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2200062064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062064.